Loading...
01/11 11:26
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: strong gross written premiums and book value per share growth are positive, but declining net income and increased expense ratio are concerning. The Q&A highlights management's focus on growth and risk management but also reveals some uncertainties, such as upward pressure on loss ratios and vague responses on key metrics. The lack of clear guidance and the absence of market cap data make it challenging to predict a strong movement. Thus, a neutral sentiment is appropriate, indicating minor stock price fluctuations.
Net Income $14 million or $0.73 per diluted share for Q2 2025, compared to $11 million or $0.57 per diluted share in Q2 2024. The increase was primarily driven by stronger valuations across equity holdings, resulting in a net unrealized gain on equity securities of $1.8 million and $3.1 million of realized gains.
Operating Net Income $10 million or $0.53 per diluted share for Q2 2025, compared to $11.1 million or $0.58 per diluted share in Q2 2024. The decrease was not explicitly explained.
Gross Written Premiums $79.7 million in Q2 2025, up 4.3% from $76.4 million in Q2 2024. The increase was driven by a $1.5 million rise in audit premiums compared to $7.3 million in the prior year, and 12.8% voluntary premium growth fueled by new business production and strong retention.
Expense Ratio 31.3% in Q2 2025, compared to 29.8% in Q2 2024. The increase was due to ongoing investment in growth, a decline in audit premium, and a 100 basis point increase in insurance-based assessments.
Net Investment Income $6.7 million in Q2 2025, down 10.2% from Q2 2024. The decrease was driven by a reduction in investable assets following the payment of a special dividend.
Book Value Per Share $13.96 as of Q2 2025, up 3.3% year-to-date. The increase was attributed to strong capital management and operational performance.
Statutory Surplus $257 million as of Q2 2025, compared to $235 million at year-end 2024. The increase reflects a strong balance sheet and conservative investment portfolio.
Voluntary Premium Growth: 12.8% growth in voluntary premiums for policies written in the quarter, driven by new business production and strong retention.
Market Positioning: Workers' compensation remains the most profitable in the property and casualty space. AMERISAFE is well-positioned operationally and financially to respond to market changes.
Policy Count Growth: In-force policy count grew 3.4% in the quarter, supported by new business growth and 93.8% renewal retention.
Loss Experience: Frequency was down compared to Q2 2024, and severity trends are within expectations. Current accident year loss ratio was 71%.
Favorable Development: $8.6 million of favorable development in the quarter, primarily from accident years 2020 and prior.
Expense Ratio: Increased to 31.3% from 29.8% in the prior year, reflecting ongoing investment in growth and insurance-based assessments.
Share Repurchase Program: Board reauthorized a $25 million share repurchase program, replacing the prior program.
Dividend Declaration: Declared a regular quarterly cash dividend of $0.39 per share, payable on September 26, 2025.
Market Conditions: Workers' compensation approved loss costs are down mid-single digits, with California experiencing an 8.7% increase. This could signal a potential shift in the market cycle, which may impact profitability.
Medical Severity: NCCI reported a 6% increase in medical severity for 2024, which could lead to higher claims costs and impact underwriting profitability.
Expense Ratio: The expense ratio increased to 31.3% from 29.8% in the prior year, driven by ongoing investments in growth and increased insurance-based assessments. This could pressure profitability if not managed effectively.
Audit Premiums: Audit premiums have declined compared to the prior year, which could impact net premiums earned and overall revenue.
Investment Income: Net investment income decreased by 10.2% due to a reduction in investable assets following the payment of a special dividend. This could affect overall financial performance.
Market Conditions: The workers' compensation market remains competitive and profitable, with the industry's combined ratio below 100% for 2024. However, there are signs of potential market shifts, such as a 6% increase in medical severity for 2024 and an 8.7% increase in approved loss costs in California, which could indicate a hardening market cycle.
Operational Positioning: AMERISAFE is well-positioned to respond to market conditions, whether the market remains soft or begins to harden, ensuring consistent underwriting profitability.
Expense Ratio: The full-year expense ratio is anticipated to align with previous years, despite a current quarter increase due to insurance-based assessments and a mismatch between voluntary premiums and audit premiums.
Investment Portfolio: The reinvestment rate environment remains strong, with yields on new investments exceeding portfolio roll-off by 230 basis points. The tax-equivalent book yield is 3.85%, and the portfolio remains high quality with an average AA- credit rating.
Quarterly Cash Dividend: The company's Board of Directors declared a regular quarterly cash dividend of $0.39 per share payable on September 26, 2025, to shareholders of record as of September 12, 2025.
Share Repurchase Program: On July 23, 2025, the Board of Directors approved the reauthorization of a $25 million share repurchase program, replacing the prior program. Since the inception of the initial program in February 2010, approximately 1.75 million shares have been repurchased at an average cost of $25.69 per share, totaling $44.8 million. During the second quarter of 2025, the company repurchased 63,000 shares at an average cost of $44.55, totaling $2.8 million.
The earnings call presents a mixed picture: strong underwriting and policyholder retention, but slight decreases in net income and investment income. The Q&A reveals confidence in growth strategy and stable competitive landscape, but concerns about medical inflation and large losses persist. Despite a positive book value increase, no new partnerships or significant guidance changes were announced. The market's competitive nature and lack of immediate expansion plans further balance the sentiment. Given these factors, the stock price is likely to remain stable over the next two weeks, resulting in a neutral sentiment rating.
The earnings call presents a mixed picture: strong gross written premiums and book value per share growth are positive, but declining net income and increased expense ratio are concerning. The Q&A highlights management's focus on growth and risk management but also reveals some uncertainties, such as upward pressure on loss ratios and vague responses on key metrics. The lack of clear guidance and the absence of market cap data make it challenging to predict a strong movement. Thus, a neutral sentiment is appropriate, indicating minor stock price fluctuations.
The earnings call presented a mixed picture. Financial performance showed growth in premiums and a stable combined ratio, but net income and investment income declined. The dividend increase is positive, but the lack of a share buyback plan and higher expenses are concerning. The Q&A revealed some uncertainties, particularly regarding economic factors and competitive pressures. Overall, the positive and negative aspects balance each other, leading to a neutral sentiment.
The earnings call reveals mixed signals. While there's a dividend increase, which is positive, the overall financial performance shows declines in net income and investment income, causing concern. The Q&A highlights stable policy growth but also competitive pressures and unclear responses from management. Despite some optimism in policy retention, the financial metrics and management's evasiveness lead to a neutral outlook.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
